Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis

Annals of Neurology

Volumn 49, Issue 2, 2001, Pages 176-185

  Almer, Gabrielle ^a   Guégan, Christelle ^a   Teismann, Peter ^a   Naini, Ali ^a   Rosoklija, Gorazd ^a   Hays, Arthur P ^a   Chen, Caiping ^a   Przedborski, Serge ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HORN CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BRAIN; CYCLOOXYGENASE 2; INFLAMMATION; ISOENZYMES; MICE; MICE, TRANSGENIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SPINAL CORD;

EID: 0035132167     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X     Document Type: Article

References (52)

1. Hereditary and acquired motor neuron diseases
2. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
3. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
4. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
5. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
6. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
7. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis
8. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS)
9. Neuropathology of ALS: An overview
10. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS
11. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis
12. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis
13. Reactive astrocytes: Cellular and molecular cues to biological function
14. Microglia as mediators of inflammatory and degenerative diseases
15. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
16. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: Immunological parameter and comparison with inflammatory and noninflammatory central nervous system diseases
17. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
18. Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration
19. Inhibition of ICE slows ALS in mice
20. Mediation of inflammation by cyclooxygenase-2
21. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology
22. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
23. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis
24. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
25. Brain superoxide dismutase, catalase and glutathione peroxidase activities in amyotrophic lateral sclerosis
26. Characterization of inducible cyclooxygenase in rat brain
27. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
28. Subcellular localization of prostaglandin endoperoxide H synthase-1 and -2 by immunoelectron microscopy
29. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia
30. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture
31. Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures
32. Expression and regulation of cyclooxygenase-2 in rat microglia
33. Mechanisms of selective motor neuron death in ALS: Insights from transgenic mouse models of motor neuron disease
34. Cyclooxygenase-2 induction in cerebral cortex: An intracellular response to synaptic excitation
35. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis
36. Transforming growth factor 1β regulates the expression of cyclooxygenase in cultured cortical astrocytes and neurons
37. The neuromessenger platelet-activating factor in plasticity and neurodegeneration
38. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog
39. Regulation of biosynthesis of nitric oxide
40. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
41. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
42. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase
43. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis
44. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis
45. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis
46. Regulatory functions of phospholipase A2
47. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration
48. Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: A c-Myc-dependent and Bcl-2-independent associated pathway
49. Role of thymus-eicosanoids in the immune response
50. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
51. Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis